HLA-DRB1 and myeloid sarcoma: Therefore, the elevated MS risk after IM of 3.2 and of 7 in individuals carrying the main genetic risk factor for MS, the HLA-DRB1*1501 MHC class II allele [24,34], might in part explain the geographical distribution of MS.